相关实验视频

Updated: Jun 3, 2025

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

辐射诱导的心脏病:现代技术来减少心脏毒性

Amichay Meirovitz¹, Kim Sheva¹

¹The Legacy Heritage Oncology Center & Dr Larry Norton Institute, Soroka University Medical Center, Ben Gurion University of the Negev, Faculty of Medicine, Be'er Sheva, Israel.

Practical radiation oncology

|January 8, 2025

概括

辐射诱导的冠心病 (RICHD) 是癌症幸存者治疗中腔辐射的日益关注的问题. 虽然心脏节约技术正在得到改进,但RICHD仍然是幸存者护理的一个重大挑战.

科学领域:

心脏病学心脏病学
在瘤学瘤学.
辐射瘤学辐射瘤学

背景情况:

由于治疗的进步,癌症的生存率正在增加.
放射治疗相关的疾病,特别是辐射诱导冠心病 (RICHD),正变得越来越明显.
RICHD是治疗中腔辐射的幸存者患病和死亡的主要原因.

研究的目的:

审查有关RICHD在特定癌症类型 (霍奇金淋巴瘤,乳腺,肺部) 的文献.
检查旨在最大限度地减少心脏辐射暴露的现代放射治疗技术.

主要方法:

文献综述侧重于RICHD和心脏保护策略.
对霍奇金淋巴瘤,乳腺癌和肺癌治疗中使用的技术的分析.

主要成果:

存在各种策略,以最大限度地减少心脏辐射暴露在中枢膜放射治疗期间.
技术包括优化划线,深呼吸呼吸 (mDIBH) 和节省心脏的方法.
医疗和身体保护方法的结合可能对心脏保护至关重要.

结论:

尽管在保护策略和剂量规划方面取得了进展,但RICHD仍然是一个重大挑战.
通过身体距离和先进的计划,尽量减少心脏暴露是关键.
在癌症治疗,康复和生存方面,RICHD仍然是一个关键问题.

更多相关视频

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease

Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease

Published on: February 8, 2022

相关概念视频

Imaging Studies for Cardiovascular System III: X-Ray

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

Heart Failure Drugs: Inotropic Agents

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...